129 results
Page 3 of 7
6-K
EX-99.1
95bk6rmbj4y
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.5
le7xr0z6w ahh8yny
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.6
4vvxch3mlwzvt22
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
5gkelf2q833adivel3
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.2
b41srwnvm5n
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
ysh8lustqdt5d ac
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.3
42txzyigmx k1yfwm4ke
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
a42l1om 9pwi
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
9ppnil rna
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.2
72w4cfd
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm
6-K
EX-99.2
r45sk
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.2
40esh0zztka
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.2
7vnl 1mzf6d
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.1
aehcj25g
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.1
28qcxjdw9ucz 5lwyj
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.2
u95cci
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
fvs6ny79fwnyknwn5x
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm